MSU Health Care at McLaren Greater Lansing Breast Imaging Center expands breast care capabilities
November 3, 2026 - MCLAREN GREATER LANSING
McLaren Greater Lansing, part of statewide McLaren Health Care and the Karmanos Cancer Network, has enhanced its capabilities to assess patients’ risk for developing breast and other common cancers with the addition of Volpara® Risk Pathways.
An industry-leading piece of clinical technology, the Volpara platform' determines patients’ individual and unique risk for cancers and manages their care to help ensure they receive the appropriate level of timely care.
Volpara is available to patients through all McLaren Greater Lansing’s mammography-capable diagnostic imaging centers: MSU Health Care at McLaren Greater Lansing Breast Imaging Center, McLaren Greater Lansing – Mid-Michigan Physicians Imaging Center, and McLaren Greater Lansing Grand Ledge Radiology.
“Cancer care is improving rapidly,” said Dr. David Rawson, a radiologist and Medical Director of the MSU Health Care at McLaren Greater Lansing Breast Imaging Center. “Early detection gives patients the best chance for cure. Volpara Risk Pathways allows us to customize patient recommendations based on risk, leading to earlier diagnosis, reduced suffering, and better outcomes for our patients and community.”
During their lifetime, one in eight women will be diagnosed with breast cancer, making it critical for them to receive not only regular mammography screenings but also to discuss their personal risk for developing breast cancer with their provider, who may recommend additional screenings or care.
Patients serve a key role in their individualized risk assessment by providing details of their personal and family medical history through an easily accessible digital health questionnaire.
Using the information provided, clinical teams can identify high-risk patients with the application of risk models and clinical guidelines, and those patients can be directed to follow-up care, such as mammograms, ultrasounds, and breast MRIs.
Volpara also facilitates convenient integration with leading genetic labs, allows McLaren clinicians to track patients’ progress, update their risk profiles, and generate additional communications, including educational and medical necessity materials.
Make an appointment with a McLaren Greater Lansing primary care provider to discuss and determine breast cancer risk at mclaren.org/greaterlansing.
Learn more about all services provided at McLaren Greater Lansing at mclaren.org/greaterlansing.